Obesity-Related Ion Channel Screening Service

Obesity is a massive global health challenge, driving metabolic disorders, diabetes, and cardiovascular diseases. At its core, the regulation of energy homeostasis, appetite, and metabolic rate relies heavily on complex cellular signaling pathways where ion channels play a vital role. From energy-sensing potassium channels in the hypothalamus to transient receptor potential (TRP) channels in adipose tissue, these molecular gates are increasingly recognized as high-value drug targets.

High-Fidelity Preclinical Ion Channel Screening for Obesity Target Discovery

Protheragen provides a dedicated obesity-related ion channel screening service to accelerate preclinical drug discovery. Our platform evaluates novel small molecules, biologics, and natural compounds against a specialized panel of metabolic ion channels, generating the high-quality biophysical data required to confidently advance your pipeline.

Core Technologies

To deliver precise preclinical insights, Protheragen utilizes an advanced suite of electrophysiological and optical assay technologies:

Service Scope

Our preclinical screening suite is built to cover the entire spectrum of ion channel modulation in metabolic disease, offering tailored electrophysiology options depending on your target's tissue origin and screening throughput needs.

Manual & Automated Patch Clamp Service

We bridge the gap between high-throughput efficiency and high-fidelity mechanism analysis. Our automated patch clamp service utilizes multi-channel planar arrays to quickly profile compound libraries against key metabolic targets like KATP channels, voltage-gated calcium channels (Cav), and sodium channels (Nav). When deep mechanistic resolution is needed, our manual patch clamp service steps in. This allows our scientists to study detailed state-dependent blocking, use-dependent inhibition, and complex gating kinetics in single cells. This dual approach gives you both the speed for initial screening and the precision needed for lead optimization.

Brain Slice Patch Clamp Service

Appetite regulation and energy expenditure are orchestrated within complex neuronal networks in the brain, particularly in the hypothalamus. Testing compounds on isolated cells sometimes misses this network context. Protheragen provides specialized brain slice patch clamp services, recording directly from neurons in acute rodent brain slices. This ex vivo approach preserves the architecture and synaptic connections of vital metabolic centers like the arcuate nucleus. By monitoring how your drug candidates alter the firing rates and synaptic currents of POMC or AgRP neurons, we deliver highly predictive translation into In Vivo Metabolic Models.

Two-Electrode Voltage Clamp Service

For difficult-to-express ion channels or complex chimeric targets, our two-electrode voltage clamp (TEVC) service using Xenopus oocytes is an ideal solution. This robust expression platform allows for precise control of membrane potential and efficient delivery of large macro-currents. It is exceptionally well-suited for looking at structural-functional relationships of metabolic channels, evaluating large-molecule therapeutics, or testing compound activity across varying extracellular pH environments. The stability of the TEVC setup ensures reliable, reproducible pharmacology data for early-stage target validation.

Discover the Right Screen for Your Target — Connect With an Expert.

Workflow

Moving a compound from a concept on a screen to validated electrophysiological data requires a clear, step-by-step path that ensures nothing gets missed.

• Step1: Collaboratively define project parameters, selecting optimal cell lines, target ion channels, and precise screening protocols.
• Step2: Cultivate and validate target-expressing cell lines or slice preparations to guarantee stable baseline electrophysiological responses.
• Step3: Execute automated or manual electrophysiological recordings using optimized compound concentration curves and positive controls.
• Step4: Extract precise biophysical parameters, including IC50 values, activation kinetics, and state-dependent inhibition profiles.
• Step5: Compile comprehensive study reports featuring publication-grade data graphics and detailed pharmacological insights for decision-making.

Fields of Application

The biological impact of these channels stretches far beyond just appetite control, making our screening assays highly adaptable across various stages of metabolic research.

• Anti-Obesity Therapeutics Discovering and optimizing small molecules or peptides that modulate central nervous system targets regulating satiety and hunger.
• Brown Adipose Activation Profiling compounds targeting TRP or proton channels to stimulate thermogenesis and increase energy expenditure in peripheral tissues.
• Metabolic Syndrome & Diabetes Screening drug candidates that regulate insulin secretion via pancreatic ion channels, addressing root causes of metabolic dysregulation.
• Safety Pharmacology Screening early-stage metabolic leads against off-target peripheral ion channels to eliminate potential cardiotoxic or neurotoxic risks before in vivo testing.

Advantages

Working with a specialized team makes a huge difference, especially when you are dealing with the quirky biophysics of metabolic channels.

Contact Our Team for More Information and to Discuss Your Project.

Customer Review

Frequently Asked Questions

1. What specific ion channels are included in your obesity screening panel?

   We screen a wide range of targets including K_ATP channels, various TRP channels (like TRPV1, TRPM8), voltage-gated calcium (Ca_v) channels, and voltage-gated sodium (Na_v) channels involved in central or peripheral metabolic signaling. Let us know your specific target, and we can customize an assay.

2. Can you accommodate custom cell lines provided by the client?

   Yes, we frequently onboard client-validated cell lines. We perform rigorous initial testing to optimize electrophysiological expression and baseline stability before beginning any formal compound screening.

3. How do you ensure the physiological relevance of your brain slice assays?

   Our brain slice patch clamp services use acute tissue slices from specific hypothalamic regions, preserving native architecture, receptor expression, and synaptic networks to closely mimic in vivo conditions.

4. What is the typical turnaround time for an automated screening project?

   Timeline varies depending on library size, but standard automated patch clamp screenings are usually completed with full data reports delivered within 3 to 5 weeks from compound receipt.

5. Do you offer assay development services for novel metabolic targets?

   We do. If your target is unique or lacks a commercial assay, our development team can build, optimize, and validate a custom screening protocol from scratch.

6. How do you handle compound solubility issues during screening?

   Our scientists evaluate compound-vehicle compatibility (such as DMSO tolerance) during pre-screening to prevent precipitation and ensure accurate concentration-response testing.

7. Can your platforms distinguish between agonists, antagonists, and allosteric modulators?

   Yes, our precise voltage and current protocols are specifically designed to characterize the exact nature of modulation, including state-dependent and use-dependent behaviors.

8. Can Protheragen provide clinical trial testing?

   No, our services are strictly dedicated to preclinical drug discovery and optimization. We do not provide clinical trial testing or patient sample analysis.

9. What metrics do you use to ensure data quality in automated assays?

   We monitor gigaseal formation, stable baseline currents, access resistance, and positive control responses. Any data point failing our strict thresholds is flagged and re-run.

Contact Us

Navigating the complexities of ion channel biophysics requires a partner with deep scientific expertise and specialized platforms. Protheragen is committed to delivering premium, actionable preclinical data to help turn your metabolic drug concepts into validated leads. Don't let technical bottlenecks slow down your drug discovery program. Contact Protheragen!